IDR-601

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIDR-601
Drug Alias NameRNA polymerase modulators (Equispharm)RNA polymerase modulators (IDRTech)CVP-09132IDR-601CVP-09136 +[6] 
ClassificationSmall molecules
Mechanisms of ActionBacterial DNA-directed RNA polymerase modulatorsVirus replication inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIDRTech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreaPlanet Co LtdIDRTech Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A